COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge

Detalles Bibliográficos
Autores principales: Cochran, Willa, Salto-Alejandre, Sonsoles, Barker, Lindsay, Langlee, Julie, Freed, Kristin, Carter, Debra, Bannon, Jaclyn, Goddard, Dillon, Mostafa, Heba, Werbel, William, Shah, Pali, Segev, Dorry, Brennan, Daniel, Avery, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875834/
https://www.ncbi.nlm.nih.gov/pubmed/36228295
http://dx.doi.org/10.1097/TP.0000000000004418
Descripción
Sumario:

Ejemplares similares